Open original FDA record ↗Recall record
- FDA identifier
- Z-2061-2018
- Company in FDA record
- NordicNeuroLab AS
- FDA record creation date
- Jun 4, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The bug causes BOLD activation maps to be visualized as overlays without taking the coregistration into account. Any output created from these activation maps as overlays will not be adjusted according to the coregistration.
Source facts
- Action
- The firm notified their customers by email on July 3, 2015. Actions to be taken by the customer/User: We advise users to immediately stop using the BOLD module in nordiclCE and contact NordicNeuroLab for further instructions on how to upgrade the nordiclCE BOLD module, as described more fully below. For further questions, please call (262) 337-2909.
- Initiated
- 2015-07-03
- Root cause
- Software design
- Terminated
- 2020-09-16
- Distribution
- Worldwide Distribution - USA (nationwide) Distribution and to the countries of : Australia , Belgium, Brazil, China, Czech Republic, Denmark, France, Germany, Greece, Hungary, India, Italy, Japan, Kuwait, Malaysia, Netherlands, Norway and Poland.
- Recall number
- Z-2061-2018
- Recall status
- Terminated
- CDRH record ID
- 159628
- FDA record created
- 2018-06-04
- Recall event number
- 78467